Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
I129860-100mg | 100mg | In stock | $90.90 | |
I129860-200mg | 200mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $138.90 | |
I129860-250mg | 250mg | In stock | $143.90 | |
I129860-500mg | 500mg | In stock | $195.90 | |
I129860-1g | 1g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $352.90 | |
I129860-5g | 5g | In stock | $1,587.90 |
Synonyms | IRINOTECAN HYDROCHLORIDE [ORANGE BOOK] | [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;trihydrate;hydrochloride | |
---|---|
Specifications & Purity | ≥98% |
Biochemical and Physiological Mechanisms | Irinotecan hydrochloride trihydrate, Irinotecan (CPT 11), a compound within the camptothecin family, is an inhibitor of Topo I (topoisomerase I) involved in cellular DNA replication and transcription. As a Topo I inhibitor, Irinotecan inhibits the religat |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Action Type | INHIBITOR |
Mechanism of action | DNA topoisomerase I inhibitor |
Product Description | Irinotecan prevents DNA from unwinding by inhibition of topoisomerase 1. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;trihydrate;hydrochloride |
---|---|
INCHI | InChI=1S/C33H38N4O6.ClH.3H2O/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;;;;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H;3*1H2/t33-;;;;/m0..../s1 |
InChi Key | KLEAIHJJLUAXIQ-JDRGBKBRSA-N |
Canonical SMILES | CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.O.O.O.Cl |
Isomeric SMILES | CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.O.O.O.Cl |
RTECS | DW1060750 |
PubChem CID | 60837 |
Molecular Weight | 677.18 |
Reaxy-Rn | 4838283 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
L2202078 | Certificate of Analysis | Sep 13, 2024 | I129860 |
L2202093 | Certificate of Analysis | Sep 13, 2024 | I129860 |
L2202131 | Certificate of Analysis | Sep 13, 2024 | I129860 |
L2202134 | Certificate of Analysis | Sep 13, 2024 | I129860 |
L2202135 | Certificate of Analysis | Sep 13, 2024 | I129860 |
I2228201 | Certificate of Analysis | Jul 04, 2024 | I129860 |
K2429262 | Certificate of Analysis | Apr 29, 2024 | I129860 |
K2429267 | Certificate of Analysis | Apr 29, 2024 | I129860 |
F2201218 | Certificate of Analysis | Mar 15, 2024 | I129860 |
F2201221 | Certificate of Analysis | Mar 15, 2024 | I129860 |
F2201222 | Certificate of Analysis | Mar 15, 2024 | I129860 |
L1923069 | Certificate of Analysis | Jul 19, 2023 | I129860 |
E2128457 | Certificate of Analysis | Mar 09, 2023 | I129860 |
K2301116 | Certificate of Analysis | Oct 13, 2022 | I129860 |
C1822032 | Certificate of Analysis | Feb 17, 2022 | I129860 |
Solubility | DMSO 135 mg/mL Water 2 mg/mL Ethanol 7 mg/mL |
---|---|
Sensitivity | Heat sensitive |
Specific Rotation[α] | 24° (C=1,MeOH) |
Boil Point(°C) | 257°C |
Pictogram(s) | GHS08, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H341:Suspected of causing genetic defects H302:Harmful if swallowed H360:May damage fertility or the unborn child |
Precautionary Statements | P280:Wear protective gloves/protective clothing/eye protection/face protection. P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P281:Use personal protective equipment as required. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P301+P317:IF SWALLOWED: Get medical help. P318:if exposed or concerned, get medical advice. |
RTECS | DW1060750 |
Reaxy-Rn | 4838283 |
Merck Index | 5091 |
1. Xinxin Meng, Zhun Liu, Xubin Qian, Shaoyu Tang, Cheng Fang, Junfeng Niu, Lei Xu. (2023) Enhanced degradation mechanism of anticancer drug irinotecan through low-frequency ultrasound assisted reactive electrochemical membrane. Journal of Cleaner Production, 383 (135419). [PMID:] [10.1016/j.jclepro.2022.135419] |
1. Xinxin Meng, Zhun Liu, Xubin Qian, Shaoyu Tang, Cheng Fang, Junfeng Niu, Lei Xu. (2023) Enhanced degradation mechanism of anticancer drug irinotecan through low-frequency ultrasound assisted reactive electrochemical membrane. Journal of Cleaner Production, 383 (135419). [PMID:] [10.1016/j.jclepro.2022.135419] |